TORSELLO, ANTONIO BIAGIO
 Distribuzione geografica
Continente #
NA - Nord America 12.449
EU - Europa 4.961
AS - Asia 1.038
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 13
OC - Oceania 9
AF - Africa 4
Totale 18.489
Nazione #
US - Stati Uniti d'America 12.244
DE - Germania 1.110
IT - Italia 942
SE - Svezia 649
CN - Cina 646
IE - Irlanda 636
UA - Ucraina 587
GB - Regno Unito 291
CA - Canada 205
FI - Finlandia 164
AT - Austria 134
BE - Belgio 132
HK - Hong Kong 119
RU - Federazione Russa 83
VN - Vietnam 81
IN - India 79
FR - Francia 72
TR - Turchia 61
DK - Danimarca 52
NL - Olanda 39
BG - Bulgaria 23
EU - Europa 14
IR - Iran 13
PL - Polonia 13
JP - Giappone 12
BR - Brasile 8
KR - Corea 8
CH - Svizzera 7
AU - Australia 6
RO - Romania 6
CZ - Repubblica Ceca 5
ES - Italia 5
PT - Portogallo 5
TW - Taiwan 4
CL - Cile 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
SC - Seychelles 3
HU - Ungheria 2
IL - Israele 2
LB - Libano 2
PE - Perù 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EE - Estonia 1
GH - Ghana 1
IQ - Iraq 1
LT - Lituania 1
MD - Moldavia 1
PH - Filippine 1
SI - Slovenia 1
TH - Thailandia 1
Totale 18.489
Città #
Ann Arbor 2.635
Woodbridge 1.350
Fairfield 1.171
Frankfurt am Main 917
Chandler 916
Houston 907
Wilmington 829
Ashburn 675
Dublin 608
Jacksonville 581
Seattle 545
Cambridge 356
Dearborn 345
Milan 292
New York 264
Princeton 260
Nanjing 154
Brussels 131
Vienna 131
Hong Kong 118
Lawrence 112
Altamura 98
Lachine 97
Beijing 77
Shanghai 75
Helsinki 61
Boardman 60
San Diego 57
Detroit 50
Nanchang 48
Falls Church 47
Philadelphia 47
Guangzhou 42
Rome 41
London 39
Hebei 37
Andover 36
Toronto 35
Mountain View 31
Shenyang 31
Grafing 30
Dong Ket 29
Fremont 29
Changsha 27
Huizen 27
Pune 27
Elora 23
Jiaxing 21
Norwalk 20
Plovdiv 20
Jinan 19
Ottawa 19
Kunming 18
Renton 18
Tianjin 18
Sacramento 15
Chicago 14
University Park 14
Hangzhou 13
Ningbo 13
Monza 12
Auburn Hills 10
Bari 10
Lissone 10
Edmonton 9
Kiev 9
Kocaeli 9
Thunder Bay 9
Bonndorf 8
Russi 8
San Mateo 8
Taizhou 8
Hefei 7
Leawood 7
Southend 7
Carate Brianza 6
Changchun 6
Chiavari 6
Como 6
Hanoi 6
Los Angeles 6
Napoli 6
Pavia 6
Pescara 6
Redmond 6
Tappahannock 6
Zhengzhou 6
Arcore 5
Bergamo 5
Bologna 5
Brescia 5
Bresso 5
Sora 5
Turin 5
Zanjan 5
Zurich 5
Acton 4
Bolzano 4
Genova 4
Hanover 4
Totale 14.984
Nome #
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 339
Study of the Tissue Distribution of TLQP-21 in Mice Using [18F]JMV5763, a Radiolabeled Analog Prepared via [18F]Aluminum Fluoride Chelation Chemistry 328
Angiotensin-(1-7) exerts a protective action in a rat model of ventilator-induced diaphragmatic dysfunction 300
Growth hormone secretagogues and the regulation of calcium signaling in muscle 290
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 275
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 272
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 251
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 250
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 237
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 220
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 209
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 202
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 197
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 195
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 191
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 191
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 186
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 184
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 183
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 181
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 181
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 180
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 177
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 176
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 174
TLQP-21 modulate inflammation and fibrosis in a model of ards 172
Feeding behavior during long-term hexarelin administration in young and old rats 169
Somatotropic dysregulation in old mammals 166
Ghrelin in gastroenteric pathophysiology 165
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structure 163
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 163
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 162
Somatostatin Withdrawal as Generator of Pulsatile GH Release in the Dog: A Possible Tool to Evaluate the Endogenous GHRH Tone? 161
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 161
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 159
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 159
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 156
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 156
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 156
Cisplatin-induced skeletal muscle dysfunction: Mechanisms and counteracting therapeutic strategies 156
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 155
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 153
Progressive seizure aggravation in the repeated 6-Hz corneal stimulation model is accompanied by marked increase in hippocampal p-ERK1/2 immunoreactivity in neurons 153
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 152
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 151
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 149
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 149
Ghrelin regulates proliferation and differentiation of osteoblastic cells. 148
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 145
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 143
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 143
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 143
Regulation of galanin by dexamethasone in the rat anterior pituitary and the uterus 143
Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat 142
Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia 142
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 141
Growth hormone secretagogues: focus on the growth hormone-releasing peptides 141
Growth hormone-inhibiting activity of cortistatin in the rat 139
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 139
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 139
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 138
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 138
Intrarticular cytokines and resolvin after ACL and meniscal tear in skeletally immature patients 138
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 137
Characterization of synovial cytokine patterns in bucket-handle and posterior horn meniscal tears 137
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 136
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 136
Calcium signaling and secretory responses in agonist-stimulated pituitary gonadotrophs 136
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 135
Steroids and tissue-specific modulation of galanin gene expression in the male rat reproductive system 135
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 135
Pyruvate and satiety: can we fool the brain? 133
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 133
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 132
Pathophysiogenesis of Mesial Temporal Lobe Epilepsy: Is Prevention of Damage Antiepileptogenic? 132
Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy 131
Ghrelin injected into the paraventricular nucleus of the hypothalamus of male rats induces feeding but not penile erection 130
Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa 130
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 130
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 130
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 128
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 127
Role of the neuronal histaminergic system in the regulation of somatotropic function: Comparison between the neonatal and the adult rat 127
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications 127
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 126
Age-related modulatory activity by a cholinergic agonist on the growth hormone response to GH-releasing hormone in the rat 126
Growth hormone-independent cardioprotective effects of hexarelin in the rat 126
EP 60761- and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid 125
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 125
Growth hormone-releasing factor (GRF) regulates expression of its own receptor 125
Modifications of plasma concentrations of hormonal and tissue factors during mechanical ventilation with positive end-expiratory pressure 124
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat 122
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 122
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice 121
Farmacologia endocrina 121
Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes 120
Hexarelin stimulation of growth hormone release and mrna levels in an infant and adult rat model of impaired ghrh function 120
Glycosaminoglycans boost insulin-like growth factor-I-promoted neuroprotection: blockade of motor neuron death in the wobbler mouse 117
La somatopausa: nuove prospettive terapeutiche 116
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations 115
Totale 16.045
Categoria #
all - tutte 48.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.179


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.239 0 0 0 0 0 0 0 0 108 238 443 450
2019/20203.546 410 149 266 353 359 421 479 261 370 169 222 87
2020/20212.818 178 187 269 300 232 227 234 229 236 298 186 242
2021/20221.905 149 182 233 139 100 178 85 70 109 172 152 336
2022/20233.725 375 937 375 361 290 505 96 210 237 78 164 97
2023/20241.770 111 111 120 135 297 500 419 74 3 0 0 0
Totale 19.007